United States Biotechnology & Medical Research

VIA Pharmaceuticals Inc (VIAP)

Track

Ticker: VIAP Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Taub Rebecca SVP, Research & Development Officer
Transaction date
Purchase
Price
449.19
Quantity 73,099 -49.4%
Value US$2,620,459
Flynn James E Possible Member of 10% Group Large shareholder
Transaction date
Sale
Price
87.31
Quantity 11,034 -9.6%
Value US$1,637,035
Flynn James E Possible Member of 10% Group Large shareholder
Transaction date
Sale
Price
209.74
Quantity 71,569 -19.3%
Value US$963,968
Flynn James E Possible Member of 10% Group Large shareholder
Transaction date
Sale
Price
3.38
Quantity 64 -0.0%
Value US$216
Flynn James E Possible Member of 10% Group Large shareholder
Transaction date
Sale
Price
3.38
Quantity 36 -0.0%
Value US$122
Flynn James E Possible Member of 10% Group Large shareholder
Transaction date
Sale
Price
3.97
Quantity 74 -0.0%
Value US$293
Flynn James E Possible Member of 10% Group Large shareholder
Transaction date
Sale
Price
3.97
Quantity 42 -0.0%
Value US$167
Flynn James E Possible Member of 10% Group Large shareholder
Transaction date
Sale
Price
3.92
Quantity 1,459 -0.1%
Value US$5,725
Flynn James E Possible Member of 10% Group Large shareholder
Transaction date
Sale
Price
3.92
Quantity 848 -0.1%
Value US$3,327
Flynn James E Large shareholder
Transaction date
Sale
Price
3.88
Quantity 1,359 -0.1%
Value US$5,267
Flynn James E Large shareholder
Transaction date
Sale
Price
3.88
Quantity 790 -0.1%
Value US$3,062
Flynn James E Large shareholder
Transaction date
Sale
Price
3.91
Quantity 8,322 -0.6%
Value US$32,576
Flynn James E Large shareholder
Transaction date
Sale
Price
3.91
Quantity 4,845 -0.6%
Value US$18,966
Flynn James E Large shareholder
Transaction date
Sale
Price
3.97
Quantity 64 -0.0%
Value US$254
Flynn James E Large shareholder
Transaction date
Sale
Price
3.97
Quantity 36 -0.0%
Value US$143
Flynn James E Large shareholder
Transaction date
Sale
Price
3.98
Quantity 445 -0.0%
Value US$1,771
Flynn James E Large shareholder
Transaction date
Sale
Price
3.98
Quantity 259 -0.0%
Value US$1,031
Flynn James E Large shareholder
Transaction date
Sale
Price
3.98
Quantity 582 -0.0%
Value US$2,316
Flynn James E Large shareholder
Transaction date
Sale
Price
3.98
Quantity 338 -0.0%
Value US$1,345
Flynn James E Large shareholder
Transaction date
Sale
Price
4.03
Quantity 3,430 -0.3%
Value US$13,807
Flynn James E Large shareholder
Transaction date
Sale
Price
4.03
Quantity 1,995 -0.3%
Value US$8,030
ANDERSON RICHARD L Non-Executive Director
Transaction date
Purchase
Price
2.43
Quantity 10,000 +inf%
Value US$24,300
BAY CITY CAPITAL LLC Large shareholder
Transaction date
Purchase
Price
2.43
Quantity 2,328 +48.4%
Value US$5,657
BAY CITY CAPITAL LLC Large shareholder
Transaction date
Purchase
Price
2.43
Quantity 128,477 +48.4%
Value US$312,199
BAY CITY CAPITAL LLC Large shareholder
Transaction date
Purchase
Price
2.43
Quantity 11,642 +48.4%
Value US$28,290
BAY CITY CAPITAL LLC Large shareholder
Transaction date
Purchase
Price
2.43
Quantity 642,384 +48.4%
Value US$1,560,993
BAY CITY CAPITAL LLC Large shareholder
Transaction date
Purchase
Price
2.43
Quantity 69,232 +48.4%
Value US$168,234
BAY CITY CAPITAL LLC Large shareholder
Transaction date
Purchase
Price
2.43
Quantity 3,211,919 +48.4%
Value US$7,804,963
FALKENBERG ERIC N
Transaction date
Purchase
Price
5.99
Quantity 12,500 +inf%
Value US$74,875
FALKENBERG ERIC N
Transaction date
Purchase
Price
6.09
Quantity 12,500 +125.0%
Value US$76,125
GILSTRAP JAMES C
Transaction date
Purchase
Price
5.50
Quantity 25,000 +460.7%
Value US$137,500
2.3
CALLICUTT JACK W VP-Finance&Admin, Chf Acct Off
Transaction date
Purchase
Price
5.50
Quantity 1,000 +inf%
Value US$5,500
2.0
MERRIMAN RONALD
Transaction date
Purchase
Price
5.50
Quantity 1,500 +inf%
Value US$8,250
FALKENBERG ERIC N
Transaction date
Purchase
Price
5.50
Quantity 10,000 +inf%
Value US$55,000
LARSON JOHN RANDOLPH
Transaction date
Purchase
Price
5.50
Quantity 18,000 +328.3%
Value US$99,000
OTTO RICHARD E Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.50
Quantity 5,000 +118.1%
Value US$27,500
SCHMITT VICTOR W
Transaction date
Purchase
Price
5.50
Quantity 10,000 +211.4%
Value US$55,000
NICHOL F RICHARD PHD
Transaction date
Purchase
Price
5.50
Quantity 1,000 +inf%
Value US$5,500
ATWOOD ROBERT T CFO, Executive VP Executive Director
Transaction date
Purchase
Price
5.50
Quantity 5,000 +25.7%
Value US$27,500
ROYSTON IVOR
Transaction date
Purchase
Price
5.50
Quantity 10,909 +9.4%
Value US$60,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2008-12-19 2008-12-05 B Purchase Taub Rebecca

SVP, Research & Development

Officer
73,099 -49.4%
449.19
US$2,620,459 		73,099 -49.4% 449.19 US$2,620,459
2007-11-07 2007-11-06 S Sale Flynn James E

Possible Member of 10% Group

Large shareholder
11,034 -9.6%
87.31
US$1,637,035 		11,034 -9.6% 87.31 US$1,637,035
2007-11-07 2007-11-06 S Sale Flynn James E

Possible Member of 10% Group

Large shareholder
71,569 -19.3%
209.74
US$963,968 		71,569 -19.3% 209.74 US$963,968
2007-11-07 2007-11-05 S Sale Flynn James E

Possible Member of 10% Group

Large shareholder
64 -0.0%
3.38
US$216 		64 -0.0% 3.38 US$216
2007-11-07 2007-11-05 S Sale Flynn James E

Possible Member of 10% Group

Large shareholder
36 -0.0%
3.38
US$122 		36 -0.0% 3.38 US$122
2007-11-02 2007-10-31 S Sale Flynn James E

Possible Member of 10% Group

Large shareholder
74 -0.0%
3.97
US$293 		74 -0.0% 3.97 US$293
2007-11-02 2007-10-31 S Sale Flynn James E

Possible Member of 10% Group

Large shareholder
42 -0.0%
3.97
US$167 		42 -0.0% 3.97 US$167
2007-10-30 2007-10-26 S Sale Flynn James E

Possible Member of 10% Group

Large shareholder
1,459 -0.1%
3.92
US$5,725 		1,459 -0.1% 3.92 US$5,725
2007-10-30 2007-10-26 S Sale Flynn James E

Possible Member of 10% Group

Large shareholder
848 -0.1%
3.92
US$3,327 		848 -0.1% 3.92 US$3,327
2007-10-26 2007-10-25 S Sale Flynn James E Large shareholder
1,359 -0.1%
3.88
US$5,267 		1,359 -0.1% 3.88 US$5,267
2007-10-26 2007-10-25 S Sale Flynn James E Large shareholder
790 -0.1%
3.88
US$3,062 		790 -0.1% 3.88 US$3,062
2007-10-26 2007-10-24 S Sale Flynn James E Large shareholder
8,322 -0.6%
3.91
US$32,576 		8,322 -0.6% 3.91 US$32,576
2007-10-26 2007-10-24 S Sale Flynn James E Large shareholder
4,845 -0.6%
3.91
US$18,966 		4,845 -0.6% 3.91 US$18,966
2007-10-26 2007-10-23 S Sale Flynn James E Large shareholder
64 -0.0%
3.97
US$254 		64 -0.0% 3.97 US$254
2007-10-26 2007-10-23 S Sale Flynn James E Large shareholder
36 -0.0%
3.97
US$143 		36 -0.0% 3.97 US$143
2007-10-26 2007-10-22 S Sale Flynn James E Large shareholder
445 -0.0%
3.98
US$1,771 		445 -0.0% 3.98 US$1,771
2007-10-26 2007-10-22 S Sale Flynn James E Large shareholder
259 -0.0%
3.98
US$1,031 		259 -0.0% 3.98 US$1,031
2007-10-19 2007-10-18 S Sale Flynn James E Large shareholder
582 -0.0%
3.98
US$2,316 		582 -0.0% 3.98 US$2,316
2007-10-19 2007-10-18 S Sale Flynn James E Large shareholder
338 -0.0%
3.98
US$1,345 		338 -0.0% 3.98 US$1,345
2007-10-19 2007-10-17 S Sale Flynn James E Large shareholder
3,430 -0.3%
4.03
US$13,807 		3,430 -0.3% 4.03 US$13,807
2007-10-19 2007-10-17 S Sale Flynn James E Large shareholder
1,995 -0.3%
4.03
US$8,030 		1,995 -0.3% 4.03 US$8,030
2007-08-10 2007-08-08 B Purchase ANDERSON RICHARD L Non-Executive Director
10,000 +inf%
2.43
US$24,300 		10,000 +inf% 2.43 US$24,300
2007-08-08 2007-08-08 B Purchase BAY CITY CAPITAL LLC Large shareholder
2,328 +48.4%
2.43
US$5,657 		2,328 +48.4% 2.43 US$5,657
2007-08-08 2007-08-08 B Purchase BAY CITY CAPITAL LLC Large shareholder
128,477 +48.4%
2.43
US$312,199 		128,477 +48.4% 2.43 US$312,199
2007-08-08 2007-08-08 B Purchase BAY CITY CAPITAL LLC Large shareholder
11,642 +48.4%
2.43
US$28,290 		11,642 +48.4% 2.43 US$28,290
2007-08-08 2007-08-08 B Purchase BAY CITY CAPITAL LLC Large shareholder
642,384 +48.4%
2.43
US$1,560,993 		642,384 +48.4% 2.43 US$1,560,993
2007-08-08 2007-08-08 B Purchase BAY CITY CAPITAL LLC Large shareholder
69,232 +48.4%
2.43
US$168,234 		69,232 +48.4% 2.43 US$168,234
2007-08-08 2007-08-08 B Purchase BAY CITY CAPITAL LLC Large shareholder
3,211,919 +48.4%
2.43
US$7,804,963 		3,211,919 +48.4% 2.43 US$7,804,963
2004-05-17 2004-05-12 B Purchase
FALKENBERG ERIC N
12,500 +inf%
5.99
US$74,875 		12,500 +inf% 5.99 US$74,875
2004-05-17 2004-05-12 B Purchase
FALKENBERG ERIC N
12,500 +125.0%
6.09
US$76,125 		12,500 +125.0% 6.09 US$76,125
2004-05-11 2004-05-07 B Purchase
GILSTRAP JAMES C
25,000 +460.7%
5.50
US$137,500 		25,000 +460.7% 5.50 US$137,500
2004-05-11 2004-05-07 B Purchase
2.3
CALLICUTT JACK W

VP-Finance&Admin, Chf Acct Off
1,000 +inf%
5.50
US$5,500 		1,000 +inf% 5.50 US$5,500
2004-05-11 2004-05-07 B Purchase
2.0
MERRIMAN RONALD
1,500 +inf%
5.50
US$8,250 		1,500 +inf% 5.50 US$8,250
2004-05-11 2004-05-07 B Purchase
FALKENBERG ERIC N
10,000 +inf%
5.50
US$55,000 		10,000 +inf% 5.50 US$55,000
2004-05-11 2004-05-07 B Purchase
LARSON JOHN RANDOLPH
18,000 +328.3%
5.50
US$99,000 		18,000 +328.3% 5.50 US$99,000
2004-05-11 2004-05-07 B Purchase
OTTO RICHARD E

Chief Executive Officer

Executive Director
5,000 +118.1%
5.50
US$27,500 		5,000 +118.1% 5.50 US$27,500
2004-05-11 2004-05-07 B Purchase
SCHMITT VICTOR W
10,000 +211.4%
5.50
US$55,000 		10,000 +211.4% 5.50 US$55,000
2004-05-11 2004-05-07 B Purchase
NICHOL F RICHARD PHD
1,000 +inf%
5.50
US$5,500 		1,000 +inf% 5.50 US$5,500
2004-05-11 2004-05-07 B Purchase
ATWOOD ROBERT T

CFO, Executive VP

Executive Director
5,000 +25.7%
5.50
US$27,500 		5,000 +25.7% 5.50 US$27,500
2004-05-11 2004-05-07 B Purchase
ROYSTON IVOR
10,909 +9.4%
5.50
US$60,000 		10,909 +9.4% 5.50 US$60,000
Explore more

More insider trading research around VIA Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America